dr. insel can talk about that better than i can, but our companies doing research at the research they at do it eventually becomes a product that can treat people. insulin is a great example of a product that is a biotechnology product that our companies helped create, and it is used for type one kids and adults who have diabetes. it is that type of thing and that type of research being done. eventually, more research will be done to treat this dreadful disease. host: can you give an example of research being done in by a medicine that will eventually help diabetics? guest: there is a lot of it. dr. insel will give you a better bet sample -- better example because jdrf is doing a lot of research on this. guest: imagine insolent in the body released on a -- insulin in the body released on glucose levels. that particular effort has been picked up by format, which illustrates that -- by pharma, which illustrates that we often work with biotechnology companies so that they can to get the full weigh

dr. insel can talk about that better than i can, but our companies doing research at the research they at do it eventually becomes a product that can treat people. insulin is a great example of a product that is a biotechnology product that our companies helped create, and it is used for type one kids and adults who have diabetes. it is that type of thing and that type of research being done. eventually, more research will be done to treat this dreadful disease. host: can you give an example of research being done in by a medicine that will eventually help diabetics? guest: there is a lot of it. dr. insel will give you a better bet sample -- better example because jdrf is doing a lot of research on this. guest: imagine insolent in the body released on a -- insulin in the body released on glucose levels. that particular effort has been picked up by format, which illustrates that -- by pharma, which illustrates that we often work with biotechnology companies so that they can to get the full weigh

dr. richard insel and scott whitaker, thank you for being on the program. we are going to go live to the senate homeland security subcommittee hearing on afghanistan reconstruction contracts. this being chaired by senator claire mccaskill, democrat of missouri. [captioning performed by national captioning institute] >> there were decisions made that were made with a myopic look at the mission, not a realistic look at security and sustainability and competency in terms of available personnel to continue whatever money we were spending on reconstruction. i always point out that the contract is probably -- if you read the initial log kept contract, if you look at everything wrong with contrasting, that would be the poster child. people may not remember that the estimates for that contract for the first year were supposed to be under $1 billion. the first year that contract cost us $20 billion. that is just one example. i'm going to try to focus today on reconstruction contracts. the sad thing about this hearing is i have been hopeful, back in 2007 that by this